Are vitiligo treatments cost-effective? A systematic review

E. McManus, T. Sach, N. J. Levell

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)
13 Downloads (Pure)


Vitiligo is characterised by well demarcated, cutaneous, macular depigmentation, with worldwide prevalence estimated to be between 0.2-1.8% [1]. Vitiligo treatments aim to encourage re-pigmentation and include topical corticosteroids, calcineurin inhibitors and NB-UVB phototherapy. Camouflage can also be prescribed to help mask the appearance of vitiligo, although this is frequently only prescribed for the face.
Original languageEnglish
Pages (from-to)e57–e58
JournalBritish Journal of Dermatology
Issue number1
Early online date29 Dec 2017
Publication statusPublished - Jan 2018

Cite this